Longevity Genes in Founder Populations
Longevity Genes in Founder Populations
批准号:
6607677
负责人:
ALAN R. SHULDINER
金额:
$70.58万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-15 至 2006-06-30
关键词:
Israel Jewish Mennonite United States blood chemistry family genetics gene environment interaction gene expression genetic mapping genetic markers geriatrics human subject human very old age (85+) linkage disequilibriums linkage mapping longevity molecular genetics nucleic acid repetitive sequence patient oriented research phenotype quantitative trait loci
中文摘要
该项目的总体目标是通过研究两个独特的创始人群体--旧秩序阿米什人和德系犹太人中的“最年长的老人”及其后代,来定位人类长寿的染色体基因座(最终是基因)。这些群体是这些研究的理想群体,因为它们是遗传上相对同质的创始人群体,以前一直是成功识别疾病基因的基础。这项建议汇集了老年病学、分子遗传学、流行病学和统计遗传学领域的一支强大的多学科研究团队,他们拥有经过验证的合作记录,并与这些封闭的人群密切合作。首先,我们将招募阿米什人和德系克肯纳兹人的先驱(年龄超过95岁)及其家人。其次,我们将通过对间隔约10 cM的391个多态短串联重复序列(STR)标记进行基因分型,并进行仅受影响的连锁分析,在多个阿米什家系中进行全基因组范围的长寿保证基因搜索。第三,我们将对阿米什人和德系克纳兹人的研究对象进行详细的表型表征。我们将通过比较先证者的后代(病例)和后代的配偶(对照)之间的平均性状差异来确定相关的与衰老相关的中间数量性状。一旦相关的衰老相关性状被确定,我们将在2000多名已经招募并进行基因分型的阿米什受试者中,使用方差成分方法在全基因组范围内搜索控制这些数量性状的基因。最后,为了加强连锁和改善连锁信号的本地化,我们将在Amish中每隔0.5-1 cM额外键入标记,并进行后续的连锁分析和关联分析,包括单倍型共享分析。这些相同的标记将在德系犹太人中进行基因分型,以可能确认这一群体中的关联,并有助于进一步缩小连锁/关联区域。作为这些研究的结果,我们将(1)鉴定两个独特的长寿和与长寿相关的表型,其中可能研究遗传和非遗传(环境)对长寿的影响;(2)通过位置克隆和位置候选基因方法确定可能含有长寿保证基因的特定染色体区域,以及(3)建立将进行纵向研究的子代队列,以便进一步定义相关的中长寿表型,并将长寿基因的遗传与其长寿表型相关联。长寿保障基因的发现将为研究衰老的分子基础以及预防和治疗与衰老相关的疾病提供新的策略。这些进步将对美国老年人的健康和生活质量产生重大影响。
英文摘要
The overall objective of this project is to localize chromosomal loci (and ultimately genes) for longevity in humans by studying the "oldest old' and their offspring in two unique founder populations, the Old Order Amish and Ashkenazi Jews. These populations are ideal for these studies because they are relatively genetically homogeneous founder populations, and previously have been the basis of successful identification of disease genes. This proposal brings together a strong multidisciplinary team of researchers in the areas of geriatrics, molecular genetics, epidemiology, and statistical genetics who have a proven track record of collaboration and who work closely with these closed populations. First, we will recruit Amish and Ashkenazi probands (age greater than 95 years) and their family members. Second, we will perform a genome-wide search for longevity assurance genes in multiplex Amish pedigrees by genotyping 391 polymorphic short tandem repeat (STR) markers spaced at approximately 10 cM intervals and performing 'affecteds' only linkage analysis. Third, we will perform detailed phenotypic characterization of Amish and Ashkenazi study subjects. We will identify relevant aging-related intermediate quantitative traits by comparing mean trait differences between the probands' offspring (cases) and the offsprings' spouses (controls). Once relevant aging-related traits are identified, we will perform a genome wide search for genes controlling these quantitative traits using variance components methods in over 2000 Amish subjects who have already been recruited and genotyped. Finally, to strengthen linkages and improve localization of linkage signals, we will type additional markers at 0.5 - 1 cM intervals in the Amish, and perform follow-up linkage analysis and association analyses, including haplotype sharing analysis. These same markers will be genotyped in Ashkenazi Jews to possibly confirm associations in this population and also to help narrow regions of linkage/association further. As a result of these studies, we will have (1) characterized two unique family collections enriched for longevity and longevity-related phenotypes in which genetic and nongenetic (environmental) influences on longevity may be studied; (2) identified specific chromosomal regions that are likely to harbor longevity assurance genes for subsequent identification through positional cloning and positional candidate gene approaches, and (3) established an offspring cohort that will be studied longitudinally in order to further define the relevant intermediate longevity phenotypes, and to correlate inheritance of longevity genes to their longevity phenotypes. Discovery of longevity assurance genes will provide critical insights into the molecular basis of aging as well as new strategies for prevention and therapy of aging-related diseases. These advances will impact substantially on the health and quality of life of older Americans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integrated Hamilton Storage System to Support the UMBioBank
-
批准号:8335016
-
项目类别:
-
资助金额:$160.33万
-
财政年份:2013
-
负责人:ALAN R. SHULDINER
-
依托单位:
Research Base
-
批准号:8020227
-
项目类别:
-
资助金额:$15.23万
-
财政年份:2010
-
负责人:ALAN R. SHULDINER
-
依托单位:
Administrative Core
-
批准号:8020195
-
项目类别:
-
资助金额:$21.54万
-
财政年份:2010
-
负责人:ALAN R. SHULDINER
-
依托单位:
Genetics of Diabetes in the Amish
-
批准号:7844255
-
项目类别:
-
资助金额:$11.54万
-
财政年份:2009
-
负责人:ALAN R. SHULDINER
-
依托单位:
Genetics Core
-
批准号:7510035
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2007
-
负责人:ALAN R. SHULDINER
-
依托单位:
PHARMACOGENETICS OF PRO 12ALA PPAR-GAMMA-2
-
批准号:7376930
-
项目类别:
-
资助金额:$0.59万
-
财政年份:2006
-
负责人:ALAN R. SHULDINER
-
依托单位:
Pharmacogenomics of CVD risk Reduction
-
批准号:7125152
-
项目类别:
-
资助金额:$145.03万
-
财政年份:2005
-
负责人:ALAN R. SHULDINER
-
依托单位:
Pharmacogenomics of Anti-platlet Intervention-2 (PAPI-2) Study
-
批准号:8322660
-
项目类别:
-
资助金额:$308.12万
-
财政年份:2005
-
负责人:ALAN R. SHULDINER
-
依托单位:
Pharmacogenomics of CVD risk Reduction
-
批准号:7677966
-
项目类别:
-
资助金额:$149.42万
-
财政年份:2005
-
负责人:ALAN R. SHULDINER
-
依托单位:
Clinical Nutrition Research Unit of Maryland
-
批准号:7665491
-
项目类别:
-
资助金额:$104.34万
-
财政年份:2005
-
负责人:ALAN R. SHULDINER
-
依托单位:
Clinical Research Career Development (RMI)
-
批准号:7692225
-
项目类别:
-
资助金额:$344.07万
-
财政年份:2005
-
负责人:ALAN R. SHULDINER
-
依托单位:
Mid-Atlantic Nutrition Obesity Research Center
-
批准号:7992648
-
项目类别:
-
资助金额:$114.58万
-
财政年份:2005
-
负责人:ALAN R. SHULDINER
-
依托单位:
Clinical Research Career Development (RMI)
-
批准号:7169529
-
项目类别:
-
资助金额:$208.84万
-
财政年份:2005
-
负责人:ALAN R. SHULDINER
-
依托单位:
Pharmacogenomics of CVD risk Reduction
-
批准号:7282518
-
项目类别:
-
资助金额:$145.05万
-
财政年份:2005
-
负责人:ALAN R. SHULDINER
-
依托单位:
Clinical Research Career Development (RMI)
-
批准号:7050365
-
项目类别:
-
资助金额:$154.0万
-
财政年份:2005
-
负责人:ALAN R. SHULDINER
-
依托单位:
Clinical Nutrition Research Unit of Maryland
-
批准号:7849856
-
项目类别:
-
资助金额:$29.77万
-
财政年份:2005
-
负责人:ALAN R. SHULDINER
-
依托单位:
Clinical Nutrition Research Unit of Maryland
-
批准号:7922345
-
项目类别:
-
资助金额:$12.65万
-
财政年份:2005
-
负责人:ALAN R. SHULDINER
-
依托单位:
Pharmacogenomics of CVD risk Reduction
-
批准号:7494150
-
项目类别:
-
资助金额:$145.07万
-
财政年份:2005
-
负责人:ALAN R. SHULDINER
-
依托单位:
PHARMACOGENETICS OF PRO 12ALA PPAR-GAMMA-2
-
批准号:7203292
-
项目类别:
-
资助金额:$3.11万
-
财政年份:2005
-
负责人:ALAN R. SHULDINER
-
依托单位:
GENOME WIDE RESEARCH FOR CVD GENE ENVIRONMENT INTERACTION
-
批准号:7203301
-
项目类别:
-
资助金额:$20.32万
-
财政年份:2005
-
负责人:ALAN R. SHULDINER
-
依托单位:
海外基金